NasdaqCM - Nasdaq Real Time Price USD

Universe Pharmaceuticals INC (UPC)

5.09

+0.62

+(13.87%)

At close: May 7 at 4:00:01 PM EDT

5.02

-0.07

(-1.38%)

Pre-Market: 5:50:17 AM EDT

Universe Pharmaceuticals Reports Full Year 2024 Earnings

Universe Pharmaceuticals ( NASDAQ:UPC ) Full Year 2024 Results Key Financial Results Revenue: US$23.0m (down 29% from...

Simply Wall St. 5 days ago

UPC
+13.87%
Universe Pharmaceuticals INC Announces Share Consolidation

Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the “Share Consolidation”). As a result of the Share Consolidat

GlobeNewswire last month

UPC
+13.87%
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

Ji’an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (the “Form 20-F”) and

GlobeNewswire 2 months ago

UPC
+13.87%
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

Ji’an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) on January 29, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company’s ordinary shares from The Nasdaq Capital Market (the “Delisting Determination”), because the bid price of the Company’s listed securi

GlobeNewswire 3 months ago

UPC
+13.87%
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to several instit

GlobeNewswire 4 months ago

UPC
+13.87%
Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering

Jiangxi, China, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (Nasdaq: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China today announced that it has entered into a definitive agreement with several investors for the purchase and sale of an aggregate of 18,750,000 of the Company’s ordinary share, par value $0.28125 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.80 per share in a regi

GlobeNewswire 4 months ago

UPC
+13.87%
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ji’an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq L

GlobeNewswire 6 months ago

UPC
+13.87%
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024. Mr. Gang Lai, Chairman of the Board of Directors and CEO of Universe Pharmaceuticals INC, commented, “During the first six months of fiscal year 2024, we navigated business uncertainties and ad

GlobeNewswire 7 months ago

UPC
+13.87%
Fall Trends in Shareholder Activism: Vinson & Elkins Partner Patrick Gadson, Live from NYSE

CorpGov hosted a fireside chat on Sept. 13 from the floor of the New York Stock Exchange with Patrick Gadson, Partner at Vinson & Elkins. Mr. Gadson spoke to Editor-in-Chief John Jannarone about the top trends to watch in shareholder activism this fall, interest rate cuts and the resulting decline in financing costs with the possible […] The post Fall Trends in Shareholder Activism: Vinson & Elkins Partner Patrick Gadson, Live from NYSE appeared first on CorpGov.

CorpGov.com 7 months ago

UPC
+13.87%

SBUX

Performance Overview

Return	UPC	S&P 500 (^GSPC)
YTD	-79.14%	-4.26%
1-Year	-99.63%	+8.55%
3-Year	-99.88%	+36.57%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Universe Pharmaceuticals INC (UPC)

Universe Pharmaceuticals Reports Full Year 2024 Earnings

Universe Pharmaceuticals INC Announces Share Consolidation

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

Fall Trends in Shareholder Activism: Vinson & Elkins Partner Patrick Gadson, Live from NYSE

Performance Overview